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ABSTRACT
Objectives: In recent years, cardiac magnetic resonance (CMR) imaging has emerged as an important tool in
the identification and characterization of cardiac masses. No imaging data on cardiac masses are available from
Pakistan. We aimed to review the clinical presentation, CMR findings, and outcome of patients referred for CMR
due to suspicion of cardiac masses on echocardiogram or computed tomography (CT).
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Material and Methods: We reviewed all the patients referred for CMR at Aga Khan University Hospital, Karachi,
from January 2011 to March 2020, with the suspicion of cardiac mass on echocardiogram and/or CT. Only those
with the confirmed diagnosis of cardiac mass on CMR were included in the study.
Results: A total of 27 patients were referred for CMR from January 2011 to March 2020, with the suspicion of
cardiac mass on echocardiogram and/or CT. Four patients were excluded as no cardiac mass was found on CMR.
Out of 23 cases, majority (n = 15, 65%) were female, age ranging from 3 months to 70 years, with a mean age
of 40 ± 22 years. Shortness of breath was the main presenting symptom (n = 19, 83%). Echocardiogram was
the initial imaging modality done in all the patients while CT was also performed in 6 patients (26%). Out of
23 patients, 4 (17%) were diagnosed to have thrombus on CMR. In two cases, it was in the left ventricle with
evidence of myocardial infarction on late gadolinium images. Myxoma was the most common tumor diagnosed
on CMR in 6 patients (26%) followed by rhabdomyoma (n = 3, 13%) and fibroma (n = 2, 8.7%). There were three
malignant primary tumors of the heart based on CMR appearances and one with tumor thrombus extension
of hepatocellular carcinoma in the right atrium from inferior vena cava. Two patients were diagnosed to have
non-neoplastic lesions – one with large intracardiac hydatid cyst and one with possible large fungal vegetation.
Among 23 patients, 9 patients (39%) underwent surgery, 5 with myxoma, 2 with rhabdomyoma, 1 with fibroma,
and 1 with fibroelastoma. Findings on surgery and histopathology matched the CMR diagnosis in all the patients
except the one with the CMR diagnosis of myxoma in which histopathology was consistent with thrombus.
Conclusion: CMR can play an important role in confirming the presence or absence of a mass in the heart. It
can also provide differentiation of non-neoplastic and neoplastic lesions and among different types of neoplastic
lesions with reasonable accuracy. However, the limitations of CMR must be recognized.
Keywords: Cardiac masses, Cardiac tumors, Cardiac magnetic resonance, Cardiac imaging, Pakistan

INTRODUCTION
Primary cardiac tumors are rare, with an estimated prevalence of 0.001–0.03% at autopsy.[1,2]
Approximately 75% of all primary cardiac tumors are benign, with myxomas being the most
frequent lesions.
is is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others
to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
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Cardiac tumors, although rare, are important and
technically difficult to diagnose using current imaging
modalities. Transthoracic echocardiography is the most
readily available non-invasive imaging technique and thus
remains the first-line diagnostic test when a cardiac tumor
is suspected.[3] However, tissue characterization by means
of echocardiography is generally limited. Cardiac computed
tomography (CT) is a commonly used second-line diagnostic
modality to assess cardiac masses.[4]
Cardiovascular magnetic resonance (CMR) imaging provides
comprehensive information and has emerged as an important
test in the identification and characterization of cardiac
masses.[5-7] CMR is non-invasive, with no risk of ionizing
radiation and wide field of view. It also provides information
about cardiac morphology and function. Compared with
CT, CMR imaging offers higher temporal resolution and
additional tissue characterization.
Cardiac masses may be non-neoplastic, for example, thrombi
or large vegetation. When there is clinical suspicion of a
cardiac mass, proper diagnostic evaluation is necessary for
appropriate treatment. CMR is important in the evaluation of
such lesions due to better tissue characterization.
No imaging data on cardiac masses are available from
Pakistan. We aimed to do the study to review the clinical
presentation, CMR findings, and outcome of patients
referred for CMR due to suspicion of cardiac masses on
echocardiogram or CT. This is the first study of its kind from
Pakistan. With the help of this study, we will get an idea about
the clinical presentation and type of cardiac tumors present
in this region and the investigative strategy which should be
adapted for the workup of cardiac masses.

CMR data acquisition
CMR was performed using a 1.5T Siemens Avanto scanner. In
each patient, a standard cardiac mass protocol was used which
included assessment of cardiac masses by morphological,
functional, and tissue characterization sequences. Images
were acquired in conventional planes and also in other planes
which best demonstrated the cardiac mass in each case.
A breath-hold steady-state free precession ECG-triggered
sequence was used for anatomical and functional assessment.
The other sequences which were obtained included turbo
spin echo T1- and T2-weighted images with and without
fat saturation, first-pass perfusion (FPP) images with
gadolinium, and late gadolinium enhancement (LGE)
images. The inversion time was optimized to null signal from
the normal myocardium.
CMR data analysis
All the images were analyzed and read by an experienced
reader in cardiovascular imaging, who was also present
at the time of image acquisition in each case. The tumor
characteristics which were assessed on CMR included tumor
size, location, attachment and mobility, signal characteristics
on different sequences, and the presence of pericardial
effusion. Signal intensity on various sequences was assessed
as hypointense, isointense, and hyperintense in relation to the
normal myocardium. Perfusion of the tumor was assessed on
FPP images and late enhancement on LGE images.

MATERIAL AND METHODS

In addition, the left and right ventricular volumes and
ejection fraction were calculated by manually drawing the
endocardial and epicardial borders in end diastole and end
systole, on the series of short-axis cine slices, using a thirdparty software – Medis QMass.

Study design

Statistical analysis

This is a retrospective observational study.

All the demographic details, presenting symptoms, CMR
findings, follow-up details about surgery, histopathology,
and outcome, were recorded. After creating a database, the
data were encoded. All statistical analyses were performed
using the Statistical Package for the Social Sciences
version 24. Continuous variables were expressed as mean
value ± standard deviation and categorical variables were
expressed as frequencies and percentage.

Study population and data collection
The study was started after getting approval from Ethical
Review Committee of Aga Khan University Hospital
(AKUH), Karachi. CMR imaging was started at AKUH,
Karachi, in 2011. We reviewed all the patients referred for
CMR at AKUH, Karachi, from January 2011 to March 2020,
with the suspicion of cardiac mass on echocardiogram and/or
CT. Only those with the confirmed diagnosis of cardiac mass
on CMR were included in the study. Data were collected by
reviewing electronic records and patients’ charts. Variables of
interest were recorded using a predesigned data entry form.
Follow-up data for surgery, histopathology, and death were
recorded by reviewing the hospital records and telephone
calls where necessary.
Journal of Clinical Imaging Science • 2020 • 10(57)
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RESULTS
Clinical presentation
A total of 27 patients were referred for CMR from January
2011 to March 2020, with the suspicion of cardiac mass on
echocardiogram and/or CT. Four patients were excluded as
no cardiac mass was found on CMR.
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Baseline characteristics of these 23 patients are summarized
in Table 1. Out of 23 cases, majority (n = 15, 65%) were
female, age ranging from 3 months to 70 years with a mean
age of 40 ± 22 years. Shortness of breath was the main
presenting symptom (n = 19, 83%). Echocardiogram was the
initial imaging modality done in all the patients while CT
was also done in 6 patients (26%).
CMR diagnosis
Table 2 shows the differentiation and frequency of different
types of cardiac masses on CMR. Out of 23 patients, 4
(17%) were diagnosed to have thrombus on CMR. In two
cases, it was in the left ventricle with evidence of myocardial
infarction on late gadolinium images. Rest of the two patients
had a history of breast carcinoma – one showed thrombus in
the right ventricle and the other in the right atrium (RA).
Table 1: Baseline characteristics.
Characteristics

Number of patients
(n=23)

Percentage

40±22
8
8
2
2
2
19
4
3
4
5
3
2
3

34.8
34.8
8.7
8.7
8.7
82.6
17.4
13
17.4
21.7
13
8.7
13

Age (Mean±SD)
Male
Hypertension
Diabetes mellitus
Coronary artery disease
Chest pain
Shortness of breath
Palpitation
Syncope
Fever
Pulmonary embolism
Stroke
History of tumor
ST-T changes on ECG

Table 2: Diagnosis on cardiac magnetic resonance.
Diagnosis
Thrombus
Myxoma
Rhabdomyoma
Fibroma
Hemangioma
Fibroelastoma
Probable lymphoma
Undifferentiated primary malignant
tumor
Tumor thrombus extension from
hepatoma
Intracardiac hydatid cyst
Possible large fungal vegetation

Number
(n=23)

Percentage

4 (+1)
6 (–1)
3
2
1
1
1
2

17.4
26.1
13
8.7
4.3
4.3
4.3
8.7

1

4.3

1
1

4.3
4.3

Myxoma was the most common tumor diagnosed on
CMR in 6 patients (26%), followed by rhabdomyoma
(n = 3, 13%), fibroma (n = 2, 8.7%), hemangioma (n =1,
4.3%), and fibroelastoma (n = 1, 4.3%). There were three
malignant primary tumors of the heart based on CMR
characteristics and one with tumor thrombus (TT) extension
of hepatocellular carcinoma (HCC) in the RA from inferior
vena cava (IVC).
One patient was diagnosed to have large intracardiac
hydatid cyst embedded in the interventricular septum and
occupying major part of the right ventricle. Another rare
case was of possible fungal vegetation in the right ventricle
attached near the tricuspid valve. It was a probable diagnosis
based on a combination of clinical features of fever,
hemoptysis, CT findings of large mycetoma in the lung
with damaged lungs due to prior tuberculosis, and large
vegetation/mass in the right ventricle on echocardiogram
and CMR.
CMR characteristics
Table 3 shows the CMR characteristics of the benign and
malignant tumors found in this study. The most common
location was intracavitary with the RA being the most
common chamber involved.
Follow-up and outcome
Among 23 patients, 9 patients (39%) underwent surgery, 5
with myxoma, 2 with rhabdomyoma, 1 with fibroma, and 1
with fibroelastoma. Findings on surgery and histopathology
matched the CMR diagnosis in all the patients except the one
with the CMR diagnosis of myxoma in which histopathology
was consistent with thrombus.
Three patients with CMR diagnosis of primary malignant
cardiac tumor died before any biopsy or surgical procedure.
Unfortunately, we could not confirm the diagnosis by
histopathology as all of them were very sick and died before
we could have done any procedure. One had CMR features of
cardiac lymphoma and the other two were non-differentiated
malignant tumors in the RA with infiltrative features and the
presence of pericardial effusion.
One fibroma patient died during the surgery and one myxoma
patient died few months after the surgery. This patient had
histologically proven right atrial myxoma with Budd-Chiari
syndrome. The patient died due to complications of BuddChiari syndrome.
Patients with cardiac thrombi were managed with
anticoagulation and showed regression in the size of thrombi
on subsequent echocardiograms.
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Table 3: Clinical and cardiac magnetic resonance characteristics of different types of tumors.
Characteristics
Age, mean±SD
Male, n (%)
Tumor location, n (%)
Left atrium
Right atrium
Left ventricle
Right ventricle
Interatrial septum
Interventricular septum
Pericardium
Pericardial effusion
Yes
No
T1-weighted images
Iso
Hypo
Hypo to iso
Hyper
Iso to hyper
Indeterminate
T2-weighted images
Iso
Hypo
Hypo to iso
Hyper
Iso to hyper
Indeterminate
First-pass perfusion
Yes
No
Indeterminate
LGE
No
Yes – patchy, heterogeneous
Yes – homogeneous, intense
Indeterminate

Myxoma
(n=5)

Rhabdomyoma
(n=3)

Fibroma
(n=2)

Hemangioma
(n=1)

Malignant
tumors (n=4)

48±17
1 (20)

5±2 mon.
1 (33.3)

26±17
1 (50)

35
0

47±23
2 (50)

2 (40)
3 (60)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)

0 (0)
1 (33.3)
1 (33.3)
0 (0)
0 (0)
0 (0)
1 (33.3)

0 (0)
0 (0)
1 (50)
0 (0)
0 (0)
1 (50)
0 (0)

0 (0)
0 (0)
1 (100)
0 (0)
0 (0)
0 (0)
0 (0)

0 (0)
3 (75)
0 (0)
0 (0)
1 (25)
0 (0)
0 (0)

0 (0)
5 (100)

0 (0)
3 (100)

0 (0)
2 (100)

0 (0)
1 (100)

3 (75)
0 (0)

3 (60)
0 (0)
1 (20)
0 (0)
0 (0)
1 (20)

3 (100)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)

1 (50)
0 (0)
0 (0)
0 (0)
1 (50)
0 (0)

1 (100)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)

0 (0)
0 (0)
0 (0)
1 (25)
1 (25)
2 (50)

0 (0)
0 (0)
0 (0)
2 (40)
2 (40)
1 (20)

0 (0)
0 (0)
0 (0)
2 (66.7)
1 (33.3)
0 (0)

1 (50)
1 (50)
0 (0)
0 (0)
0 (0)
0 (0)

1 (100)
0 (0)
0 (0)
0 (0)
0 (0)
0 (0)

0 (0)
0 (0)
0 (0)
1 (25)
1 (25)
2 (50)

4 (80)
0 (0)
1 (20)

2 (66.7)
1 (33.3)
0 (0)

2 (100)
0 (0)
0 (0)

1 (100)
0 (0)
0 (0)

3 (75)
0 (0)
1 (25)

3 (60)
2 (40)
0 (0)
0 (0)

2 (66.7)
1 (33.3)
0 (0)
0 (0)

0 (0)
0 (0)
2 (100)
0 (0)

0 (0)
1 (100)
0 (0)
0 (0)

1 (25)
2 (50)
0 (0)
1 (25)

DISCUSSION
Although small, this is the first study on CMR assessment of
cardiac masses from this region. This study shows that CMR
is excellent in excluding cardiac masses and has high accuracy
in differentiating between different types of cardiac masses.
However, similar to other imaging modalities, CMR also has
certain limitations and some cases could be misdiagnosed.
When there is uncertainty about the correct diagnosis,
histopathological assessment should be considered.
Cardiac thrombi
Thrombi are the lesions which are usually confused with
cardiac tumors. In our study, thrombus was found in 17%
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(n = 4) of the patients with confirmed cardiac mass on CMR.
The left ventricle was the site in two patients, one patient had
thrombus in the RA and one had it in the right ventricle.
The left ventricular thrombi are seen in patients with poor
myocardial contractility, usually attached to the infarcted or
scarred myocardium.[8] In our study, both the patients with
the left ventricular thrombus showed evidence of myocardial
infarction on late gadolinium images [Figure 1a-c], which
was not appreciated on echocardiogram. Rest of the two
patients had a history of breast carcinoma with apparently
hypercoagulable state.
The left atrium is another common site for cardiac thrombi, but
in our study, no patient was found with the left atrial thrombus.
The left atrial thrombi, especially in the left atrial appendage,
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are seen in patients with atrial fibrillation and mitral stenosis.
These are easily picked up on transesophageal echocardiogram
and the patients are usually not referred for CMR.
On CMR, signal intensity of thrombi varies on different
sequences according to their age. They are usually described
as hypointense masses without enhancement on postcontrast
images.[9] Subacute thrombi are iso- to hyper-intense on T1weighted images and hypointense on T2-weighted images.
Organized chronic thrombi are hypointense on both T1and T2-weighted images due to the presence of hemosiderin
deposits.[10,11] As neoplastic lesions usually have a vascularized
tissue component and thrombi are avascular, perfusion images
and LGE images are important in differentiating tumors from
thrombi. However, in chronic thrombi, some peripheral
enhancement have been reported on LGE images.[10,12]
Benign tumors
CMR features which allow us to differentiate between benign
and malignant cardiac tumors include borders, location, and
pericardial effusion. Benign tumors are usually well defined
with no irregularities or infiltration.[13]
Myxoma
Myxoma is the most common benign primary cardiac tumor,
found predominantly in women with the majority occurring

in the left atrium.[14] This was also true for our study, where
myxoma was the most common primary cardiac tumor with
female preponderance, but the distribution of location was
different. Three (60%) were in the RA while 2 (40%) in the
left atrium [Figure 2a-c].
Myxomas are pedunculated masses, usually attached to the
interatrial septum. There is heterogeneous signal intensity
on various CMR sequences, depending on the content of
the lesion. They are usually isointense to hypointense on T1weighted images and hyperintense on T2-weighted images
probably due to high water content in the myxomatous tissue.
They usually contain myxoid material as well as necrotic
or cystic and calcified material.[15] In our study, myxomas
showed similar CMR features as prior reports.[7] One case of
thrombus, which was misdiagnosed as myxoma on CMR was
a female with history of antiphospholipid antibody syndrome
and a mass in the RA near the IVC. The histopathology
showed that it was a thrombus.
Rhabdomyoma
Rhabdomyoma is the most common primary cardiac
tumor in infants and children.[16] Cardiac rhabdomyomas
are predominantly localized within the ventricles but can
be observed in the atria and may lead to obstruction of
inflow or outflow tracts. They are usually asymptomatic but
may also cause arrhythmias. There is a strong correlation
between cardiac rhabdomyomas and tuberous sclerosis. In

b

a

a

b

c

Figure 1: A 35-year-old female presented with embolic stroke,
diagnosed to have left ventricular apical thrombus with evidence of
myocardial infarction. (a) Cardiac magnetic resonance steady-state
free precession still frame in diastole showing filling defect at the left
ventricular apex (arrow). (b) Cardiac magnetic resonance steadystate free precession still frame in systole showing non-contracting
left ventricular apex with filling defect (arrow). (c) Cardiac magnetic
resonance delayed enhanced image with gadolinium, showing
transmural enhancement at the left ventricular apex with thrombus
(arrow).

c

Figure 2: A 70-year-old female presented dyspnea and syncope,
diagnosed to have left atrial myxoma. (a) Cardiac magnetic
resonance steady-state free precession still frame showing large
myxoma in the left atrium (arrow). (b) Cardiac magnetic resonance
turbo spin echo T1-weighted image, myxoma showing hypointense
to isointense signal (arrow). (c) Cardiac magnetic resonance turbo
spin echo T2-weighted image, myxoma showing hyperintense
signal (arrow).

Journal of Clinical Imaging Science • 2020 • 10(57)

| 5

Sultan and Ahmed: Cardiac magnetic resonance evaluation of cardiac masses

our study, all the three cases of rhabdomyomas were children
under 1 year of age [Figure 3a and b], and two of them were
diagnosed to have tuberous sclerosis. One of the patients had
multiple lesions involving both the left and right ventricles.
On CMR, rhabdomyomas are isointense relative to the
myocardium on T1-weighted images and hyperintense on
T2-weighted images. No significant enhancement is usually
seen on LGE images. Surgical resection is not usually
considered unless they cause symptoms of obstruction,
heart failure, or arrhythmias. However, in our study, two of
the cases underwent surgery due to unusual location, one
occupying the pericardium and the other in the RA, with
histopathology confirming the diagnosis.

a

b

Figure 3: A 3-month-old baby girl diagnosed to have right atrial
rhabdomyoma. (a) Cardiac magnetic resonance turbo spin echo
T1-weighted image, right atrial rhabdomyoma showing isointense
signal (arrow). (b) Cardiac magnetic resonance turbo spin echo T2weighted image, right atrial rhabdomyoma showing hyperintense
signal (arrow).

Cardiac fibroma
Cardiac fibroma is considered the second most common
pediatric primary cardiac tumor, usually seen as a single
lesion in an intramyocardial location.[17] In our study,
both the cases present as a well-defined mass, one in the
interventricular septum [Figure 4a-d] and the other in the
free wall of the left ventricle. One case was a 14-year-old boy
while the other was a female of 38 years.
Clinical presentation of patients with cardiac fibroma
depends on the location and size of the tumor. They can
present with symptoms of heart failure and arrhythmias.
In our study, both presented with progressively worsening
shortness of breath. In a systemic review,[18] the left
ventricle was found to be the most common site of cardiac
fibroma (57.3%), followed by the right ventricle (27.5%),
interventricular septum (17%), RA (5.3%), and left atrium
(1.8%). In our study, one was in the interventricular septum
and the other in the free wall of the left ventricle.
Fibromas are isointense to hyperintense compared to
myocardium on T1-weighted images and hypointense on T2weighted images.[19] Intense and homogeneous enhancement
on late gadolinium images is a characteristic finding of
fibroma on CMR. This is due to the accumulation and
retention of the contrast material in the wide extracellular
space of the fibrous tissue of the tumor.[20]
Surgical excision of fibromas is usually difficult as these
are embedded in the myocardium. One of our patients
underwent surgery and died on the table.
Hemangioma
Cardiac hemangiomas are usually located in the ventricles
and account for approximately 5% of cardiac tumors.
They may occur in either endocardium, myocardium,
or epicardium. On CMR SSFP cine images, cardiac
hemangioma appears as a non-mobile, non-contractile mass.
They are isointense on T1-weighted images and hyperintense
Journal of Clinical Imaging Science • 2020 • 10(57)
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b

d

Figure 4: A 38-year-old female presented with gradually worsening
dyspnea. Diagnosed to have large fibroma in the interventricular
septum. (a) Cardiac magnetic resonance steady-state free
precession still frame, showing large fibroma in the interventricular
septum (arrow). (b) Cardiac magnetic resonance turbo spin echo
T1-weighted image, fibroma showing isointense signal (arrow).
(c) Cardiac magnetic resonance turbo spin echo T2-weighted
image, fibroma showing hypointense signal (arrow). (d) Cardiac
magnetic resonance delayed enhanced image with gadolinium,
fibroma showing intense homogeneous enhancement (arrow).

on T2-weighted images. On LGE images, they show intense
enhancement with usually heterogeneous appearance due to
fibrous septum and calcification.[19] One patient had cardiac
hemangioma in our study, located in the lateral wall of the
left ventricle [Figure 5a-c].
Fibroelastoma
Fibroelastoma or papillary fibroelastoma (PFE) is the most
common primary tumor of cardiac valves and usually
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a

b

c

Figure 5: A 35-year-old female presented with dyspnea diagnosed
to have cardiac hemangioma in the lateral wall of the left ventricle.
(a) Cardiac magnetic resonance steady-state free precession still
frame, showing hemangioma in the lateral wall of the left ventricle
(arrow). (b) Cardiac magnetic resonance first-pass perfusion image
with gadolinium showing good perfusion in the hemangioma
(arrow). (c) Cardiac magnetic resonance delayed enhanced image
with gadolinium, showing intense heterogeneous enhancement in
the hemangioma (arrow).

located on the left side.[21] Its origin from non-valvular
endocardium is extremely rare. Fibroelastomas are small,
mobile, pedunculated lesions. On CMR, fibroelastomas
are isointense on T1-weighted images and hyperintense
on T2-weighted images. In our study, fibroelastoma was
found in only one patient on CMR and was confirmed on
surgery and histopathology. This was a 49-year-old man with
fibroelastoma in the RA, attached to the IVC at its junction to
the RA [Figure 6a and b]. Origin of fibroelastoma from the
RA is extremely rare with an estimated incidence of 1.8–2.3%
and non-valvular right atrial PFE is even rarer.[22] The right
atrial PFEs generally remain asymptomatic until they grow
larger in size. In our case, it was found incidentally on workup
of liver abscess. They can be fatal due to their propensity to
embolize. All symptomatic patients and patients with the
right atrial PFE of more than 10 mm should undergo surgical
resection.
Malignant tumors
In contrast to benign tumors, malignant cardiac tumors
are more likely to be ill-defined, with invasive borders and
may already be invading the pericardium at the time of
diagnosis.[23] Malignant primary cardiac tumors include
sarcomas, lymphomas, and mesothelial tumors. Sarcomas
are neoplasia of mesenchymal origin and may involve one or
more chambers as large masses occupying the entire affected

a

b

Figure 6: A 49-year-old male incidentally found to have
fibroelastoma in the right atrium, during the workup of liver
abscess. (a) Cardiac magnetic resonance steady-state free precession
still frame, showing fibroelastoma attached to the inferior vena
cava at its junction to the right atrium (arrow). (b) Cardiac
magnetic resonance steady-state free precession still frame, showing
fibroelastoma attached to the inferior vena cava at its junction to the
right atrium (arrow).

chamber or multiple chambers, with ill-defined margins and
invasive features. Associated pericardial effusion is often
present. On CMR, there may be heterogeneous enhancement
due to the presence of necrosis and hemorrhage.[15] Sarcomas
show aggressive characteristics and usually have a fatal
outcome.
In our study, there were three malignant primary cardiac
tumors based on CMR characteristics. All three patients were
very sick and died before any surgical procedure or biopsy.
In the two cases, the RA was the site of location of the tumor
with infiltrating features and presence of pericardial effusion
favoring the diagnosis of malignant tumor. These were
probably cardiac sarcomas, but we cannot be certain in the
absence of histopathology.
Cardiac lymphomas usually present as large, bulky masses
with vascular encasement without obliterating the lumen.[5,24]
In our study, one patient was probably having the cardiac
lymphoma based on CMR features. This was a 68-year-old
man with a history of weight loss, night sweats, and shortness
of breath. The tumor was involving the whole interatrial
septum and the roof of both atria, further extending outside
the heart to encase the great vessels [Figure 7a and b]. Mildto-moderate pericardial effusion was also present.
Secondary metastasis to the heart frequently manifests
as pericardial effusion. The tumors that can commonly
metastasize to the heart are melanoma, lung, breast, kidney,
and esophageal carcinomas.[25-27] Cardiac involvement may
be due to direct spread, through lymphatics, hematogenic
dissemination, or transvenous extension. On CMR,
there is no specific appearance of metastatic lesions and
signal characteristics are variable. However, postcontrast
enhancement occurs in almost all types of metastatic
lesions.[18]
In our study, no case of secondary metastatic lesion was found
except one with TT extension of HCC to the RA through the
Journal of Clinical Imaging Science • 2020 • 10(57)
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IVC. No case with secondary metastatic lesion may be due to
the referral bias as patients with secondary metastatic lesions
to the heart are usually diagnosed on echocardiogram or CT
and are not referred for CMR.
HCC is an aggressive tumor with a tendency to grow into the
blood vessels. IVC to the RA TT is an infrequent but wellrecognized complication of HCC with an incidence of 3–4%
in patients of HCC who undergo diagnostic imaging.[28] It is
associated with an increased risk of pulmonary embolism,

systemic metastases, and sudden cardiac arrest. The patient
with TT extension of HCC from IVC to RA in our study was
a known case of chronic liver disease and presented with
worsening shortness of breath. Echocardiogram revealed a
large irregular mass in the RA. Further, workup with CMR
and CT confirmed the diagnosis of HCC, with TT extension
to RA and evidence of pulmonary embolism [Figure 8a-c].
Due to lack of specific clinical signs, this condition is
probably underdiagnosed. However, with the improved
imaging studies, the incidence is increasing now. Patients
with advanced stage of the tumor or decompensated liver
disease are not suitable candidates for surgical treatment.

CONCLUSION

a

b

Figure 7: A 68-year-old male presented with dyspnea, weight
loss, night sweats, and syncope, diagnosed to have malignant
cardiac tumor (likely lymphoma). (a) Cardiac magnetic resonance
steady-state free precession still frame showing malignant cardiac
tumor (arrow). (b) Cardiac magnetic resonance steady-state free
precession still frame showing malignant cardiac tumor extending
outside the heart and encasing the great vessels (arrow).

CMR can play an important role in confirming the presence or
absence of a mass in the heart. It can also provide differentiation
of non-neoplastic and neoplastic lesions and among different
types of neoplastic lesions with reasonable accuracy. However,
the limitations of CMR must be recognized.
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